View Older Stories

Feb 25, 2026 03:46PM Ionis Pharmaceuticals (IONS) PT Raised to $95 at Morgan Stanley

Feb 25, 2026 01:20PM RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)

Feb 25, 2026 07:03AM Ionis Pharmaceuticals (IONS) Misses Q4 EPS by 8c, provides guidance

Feb 4, 2026 07:30AM BIOGEN publishes study results for high-dose nusinersen in Nature Medicine

Jan 21, 2026 07:00AM DAWNZERA gets European Commission approval for hereditary angioedema

Jan 12, 2026 11:06AM BIOGEN receives EU approval for high dose SPINRAZA for spinal muscular atrophy

Dec 17, 2025 05:28AM Ionis Pharmaceuticals (IONS) PT Raised to $95 at RBC Capital

Dec 3, 2025 08:26AM TD Cowen on Ionis Pharmaceuticals (IONS): 'New Launches And Key Pipeline Catalysts To Drive Upside'

Nov 17, 2025 06:02AM Biogen (BIIB): High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

Nov 14, 2025 07:01AM Ionis' DAWNZERA receives EU regulatory committee recommendation for HAE

Nov 13, 2025 02:00AM Ionis prices $700 million convertible notes to refinance 2026 debt

Nov 11, 2025 04:05PM Ionis announces $700 million convertible notes offering to refinance 2026 debt

Nov 11, 2025 07:39AM Bernstein on Ionis Pharmaceuticals (IONS): 'Very Positive Doc Call on SHTG Data'

Nov 10, 2025 07:30AM Ionis reports olezarsen cut triglyceride levels up to 72% in pivotal trials

Nov 6, 2025 08:02AM Ionis presents long-term DAWNZERA data at ACAAI meeting

Oct 30, 2025 05:55AM Ionis Pharmaceuticals (IONS) PT Raised to $99 at TD Cowen, Top Pick

Oct 30, 2025 05:37AM Ionis Pharmaceuticals (IONS) PT Raised to $72 at Leerink Partners

Oct 29, 2025 07:08AM Ionis Pharmaceuticals (IONS) Tops Q3 EPS by 42c, Beats on Revenue; Offers FY25 EPS Guidance

Oct 27, 2025 07:41AM Bernstein's US Biotech 3Q25 Preview: 'Expect Beats from ALNY and REGN'

Oct 9, 2025 09:26AM TD Cowen on Ionis Pharmaceuticals (IONS): 'Deep Cardio & Neuro Pipelines Set Up Continued Revs Growth'

Oct 9, 2025 05:20AM Ionis Pharmaceuticals (IONS) PT Raised to $85 at Raymond James

Oct 8, 2025 08:04AM Ionis (IONS) Hold rating reiterated at Stifel after Innovation Day presentation

Oct 8, 2025 06:37AM Ionis Pharmaceuticals (IONS) PT Raised to $90 at Oppenheimer

Oct 8, 2025 03:04AM JPMorgan Upgrades Ionis Pharmaceuticals (IONS) to Overweight

Oct 7, 2025 07:03AM Ionis hosts innovation day, targets sustained cash flow by 2028

Oct 6, 2025 09:20AM Ionis Pharmaceuticals (IONS) PT Raised to $67 at Stifel

Sep 26, 2025 05:06AM Goldman Sachs Upgrades Ionis Pharmaceuticals (IONS) to Neutral

Sep 24, 2025 04:15AM Ionis Pharmaceuticals (IONS) PT Raised to $68 at Leerink Partners

Sep 23, 2025 04:30PM FDA requests technical updates for Biogen's high dose nusinersen application

Sep 23, 2025 06:43AM Ionis Pharmaceuticals (IONS) PT Raised to $92 at Guggenheim

Sep 23, 2025 06:35AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Sep 22, 2025 12:05PM Ionis Pharmaceuticals (IONS) PT Raised to $83 at BofA Securities

Sep 22, 2025 07:00AM Ionis reports positive results for Alexander disease drug zilganersen

Sep 22, 2025 06:56AM Ionis Pharmaceuticals (IONS) Halted, News Pending

Sep 22, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Sep 19, 2025 07:01AM TRYNGOLZA approved in Europe for rare genetic syndrome FCS

Sep 12, 2025 07:01AM Ionis expands adaptive event for neurological disease communities

Sep 4, 2025 05:20AM Ionis Pharmaceuticals (IONS) PT Raised to $80 at RBC Capital

Sep 3, 2025 08:01AM Ionis Pharmaceuticals (IONS) PT Raised at Bernstein Following 'Positive Topline Results'

Sep 3, 2025 06:43AM Ionis Pharmaceuticals (IONS) PT Raised to $95 at H.C. Wainwright

Sep 3, 2025 05:04AM BMO Capital Upgrades Ionis Pharmaceuticals (IONS) to Outperform

Sep 2, 2025 03:35PM Ionis Pharmaceuticals (IONS) spreader of 5K contracts of September 55 calls and puts as share price up 35%

Sep 2, 2025 09:29AM Ionis Pharmaceuticals (IONS) PT Raised to $81 at Oppenheimer

Sep 2, 2025 07:52AM Stifel Reiterates Ionis Pharmaceuticals (IONS) at Hold, 'a highly-positive outcome for IONS'

Sep 2, 2025 07:01AM Ionis olezarsen shows 72% triglyceride reduction in Phase 3 studies

Aug 22, 2025 07:37AM Ionis Pharmaceuticals (IONS) PT Raised at Piper Sandler Following FDA Approval

Aug 22, 2025 06:51AM Ionis Pharmaceuticals (IONS) PT Raised to $70 at H.C. Wainwright

Aug 22, 2025 05:38AM Ionis Pharmaceuticals (IONS) PT Raised to $82 at Wells Fargo

Aug 21, 2025 04:02PM Ionis Pharmaceuticals (IONS) PT Raised to $69 at Citi

Aug 21, 2025 03:59PM Ionis Pharmaceuticals (IONS) PT Raised to $64 at BofA Securities

View Older Stories